Blood Pressure Medication Recalled Again due to Cancer Risk.

Blood Pressure Medication Recalled for Fifth Time due to Potential Cancer Risks.

A common blood pressure medication has been recalled for a fifth time due to concerns it contains a small amount of a cancer-causing ingredient.

Torrent Pharmaceuticals has expanded its recall of Losartan products for the fifth time. The medication contains levels of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) that are higher than the accepted amount set by the FDA.

The chemical, NMBA, is classified as a probable human carcinogen according to the FDA.

This recall comes during a larger scale of recalls including alsartan, losartan, and irbesartan that were found to contain small levels of carcinogens NMBA, N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA).

Torrent Pharmaceuticals has recalled hundreds of lots of Losartan potassium tablets since last July.

The FDA urges consumers to consult their doctor before they stop taking the recalled medication. Stopping the medication without a substitute could have greater risks.

To see if your blood pressure medication has been recalled, visit the FDA’s recall page here.

Recovering compensation after an injury from a defective product

It is a manufacturer’s responsibility to make sure their products are safe for consumers. If someone is injured due to a defective product, a product liability claim may exist. A claim may be pursued to pay for damages caused by the defective product such as medical bills, missed time from work and pain and suffering.

If you or someone you know has been seriously injured by a defective product, it is important to contact a personal injury attorney to review your rights. Call 412-661-1400 to schedule a free consultation with a personal injury lawyer in Pittsburgh at Berger and Green today.

Source: USA Today, “More blood pressure medicines recalled over possible cancer-causing impurity